iZafe Group's CFO, Marius Sandberg, has today acquired 177,793 B-shares in the company at a value of SEK 34,909 (SEK 0.196 per share).

The acquisition was completed today, November 14, bringing Marius Sandberg's total shareholding in iZafe to 177,983 B-shares.
"As the new CFO, I see the potential that exists in iZafe, and with this share purchase, I am demonstrating my confidence in the company’s future. I look forward to being part of iZafe’s growth journey and to continue working towards creating value for our shareholders and contributing to the company’s long-term success," says Marius Sandberg, CFO of iZafe Group.

iZafe Group AB (“iZafe Group”) is thrilled to announce the grand launch of Dosell in collaboration with Ti Medi, taking place in Granada on October 22-23. The event marks a pivotal moment as Ti Medi introduces its innovative concept, combining the Savioo Website and Dosell medication dispenser, to the Spanish market. Attendees at the event include 150 Ti Medi's customers, who will gain exclusive insights into Dosell and its transformative impact on medication adherence. Ti Medi's extensive network includes around 1,400 pharmacies, which significantly expanding the potential reach and impact of this innovative concept.

This launch paves the way for Dosell to become commercially available in Spain, with the first active units expected to be operational shortly. The collaboration between iZafe Group and Ti Medi represents a breakthrough in addressing the critical need for efficient and reliable medication management. The event highlights the tireless efforts and commitment of both teams in bringing this solution to life.
 
“We are incredibly proud to see the result of months of hard work and dedication as Dosell is now launched in Spain. This is a significant milestone, not only for iZafe Group but for the entire healthcare sector in Spain. Dosell will make a substantial difference in patients’ lives by simplifying their medication management. The launch also serves as strong proof of our successful partnership with Ti Medi, and we look forward to following Dosell’s impact on the Spanish market,” says Anders Segerström, CEO of iZafe Group.
 
The event in Granada serves as the official introduction of Dosell to Ti Medi's extensive network of clients, showcasing its potential to revolutionize medication adherence through an integrated system. The comprehensive approach, which includes Ti Medi's packaging technology alongside Dosell, empowers pharmacies to monitor patients’ adherence with unprecedented efficiency.
 
Marc Tarruell Tibau, CEO of Ti Medi, adds, “Bringing Dosell into our solution portfolio is a game changer. Our customers will now be able to offer an all-in-one package that significantly enhances medication management. This integration is a key step forward in improving adherence and, ultimately, patient outcomes.”
 
With Dosell now available on the Spanish market, iZafe Group is poised to continue expanding its footprint in Europe, with Spain set to become one of the key markets for the company's innovative healthcare solutions.

iZafe Group AB ("iZafe Group") today announces a strategic partnership with Randstad, a global leader in healthcare personnel services, to launch a new initiative in Norway. This collaboration aims to ensure the long-term and effective implementation of Dosell's medication dispensers across Norwegian municipalities by providing the right personnel with comprehensive training and ongoing support.

As part of our relaunch in Norway, we recognize that the most critical factor for success is effective implementation. Randstad will play a central role in managing significant parts of this implementation, regardless of which partner in Norway sells Dosell.

With the increasing demand for efficient medication management in healthcare systems, Dosell's partnership with Randstad combines technological innovation with human expertise. Randstad's strong presence in nearly all municipalities in Norway allows for tailored staffing solutions and professional development programs, ensuring that healthcare professionals are fully trained to use Dosell's cutting-edge medicine dispenser. The initiative aims to enhance patient safety and optimize medication management throughout Norway's healthcare sector.

"We are very excited to launch this partnership with Randstad in Norway, a country where we see great potential for improving medication management through our technology," says Anders Segerström, CEO of iZafe Group. "By collaborating with Randstad, which has an extensive network and deep understanding of the local healthcare landscape, we can ensure that our medicine dispenser is implemented effectively and sustainably across Norwegian municipalities. This partnership is about combining the best technology with the right people to deliver long-term, high-quality healthcare solutions."

Per Arne Lien, Manager of Health Technology at Randstad, commented, "Our extensive presence in the majority of the municipalities in Norway allows us to uniquely understand the local needs and challenges of healthcare providers. Partnering with Dosell enables us to support Norwegian municipalities with experienced, well-trained professionals who can ensure the successful integration and long-term use of Dosell's medicine dispenser. Together, we are committed to advancing healthcare quality and patient outcomes in Norway through innovation and expertise."

The partnership will begin with a pilot program across several municipalities in Norway, focusing on delivering comprehensive training for healthcare professionals and providing continuous support and advisory services. This approach ensures that Dosell's technology is not only effectively implemented but also continuously optimized to meet the evolving needs of healthcare providers and their patients.

About Dosell
The medicinal robot Dosell is a Swedish-made digital aid for safer medication at home and for people living in nursing homes. Dosell is integrated into welfare platforms and is sold as one of several integrated digital aids via partners.
In a Swedish report, it is estimated that 3,000 Swedes die annually from drug-related injuries and that 6–16 percent of hospital admissions are drug-related. The costs for drug-related injuries that can be avoided are estimated at SEK 5.6–24.6 billion per year.
Dosell notifies the patient when it's time to take the medicine, and if the medicine is not taken despite the reminders, Dosell alerts healthcare professionals or relatives who can quickly prevent an injury and improve compliance, thus minimizing drug-related injuries.
Read more at www.dosell.se

About Randstad
Randstad is a global leader in HR services, specializing in staffing, talent management, and workforce solutions. In Norway, Randstad has a significant presence across nearly all municipalities, providing skilled professionals to support local healthcare services and other sectors.

iZafe Group AB ("iZafe Group") today announces a strategic tripartite collaboration with Zafe Care Systems AB and Sensorem AB. This partnership, building on previous successes in municipal care, represents a significant step forward in providing users with increased independence and safety in their medication management, regardless of their location.

Dosell has already established itself as a leading solution for safe and efficient medication management. By automating the dosing and distribution of medications, Dosell reduces the risk of taking the wrong medication, double dispensing, and frees up valuable time for healthcare staff. Now, with the integration of Sensorem’s mobile safety alarm, the next step is being taken to offer a holistic solution that places the user’s freedom and safety at the forefront.

The Sensorem watch not only serves as a reminder to take medications, such as insulin, but also functions as a mobile safety alarm that is constantly present. If a user is far from home and does not take their medication on time, an alert is sent directly to the watch, ensuring that the appropriate actions can be taken immediately. This creates a unique combination of security and independence, allowing the user to live an active life without worrying about their health.

“With this collaboration between iZafe Group, Zafe Care Systems, and Sensorem, we are offering not just a solution for safe medication management, but also a new level of independence and security for users. Our vision is for our products to be easily integrated and become part of a comprehensive solution, showcasing the strength of Dosell. By developing products and services that can seamlessly interact with other systems, we aim to create the best possible solution for both users and healthcare professionals, without the need to manage multiple apps and systems,” says Anders Segerström, CEO of iZafe Group AB.

Per la Fleur, CEO of Zafe Care Systems AB, adds: “By combining Dosell’s reliability with Sensorem’s mobile safety alarm, we are creating an unbeatable solution that not only improves the quality of care but also gives the user the freedom to live an independent life. This is the future of healthcare technology, and we are proud to be part of this development.”

Bobo Delemark, CEO of Sensorem AB, emphasizes: “The Dosell medication dispenser and Sensorem’s mobile safety alarm together form a unique combination that is beneficial for both the user and the municipality. The user can, for example, be in a different location and be notified that medication needs to be taken (both verbally and in text), and healthcare staff can initially call the mobile alarm to ensure the medication is taken.”

About Zafe Care Systems AB: Zafe Care Systems AB specializes in developing technological solutions for healthcare and social care. With a focus on user-friendliness and safety, Zafe delivers innovative products that improve the quality of care and increase the independence of users. www.zafe.se

About Sensorem: Sensorem develops mobile safety alarms and security solutions that provide users with increased safety and freedom in their daily lives. By combining advanced technology with ease of use, Sensorem offers products that are both reliable and flexible. https://www.sensorem.com/sv/

iZafe Group AB ("iZafe Group") today announces the receipt of an official order for 500 units of Dosell from Ti Medi, a dedicated partner of iZafe Group since April 2023. These units have recently been produced and will be delivered to Spain in August 2024, in time for Ti Medi's planned launch this fall of their new unique concept for the Spanish market.

Ti Medi, in collaboration with its 1400 pharmacies, will launch an innovative solution that combines their dose packaging machines with the Dosell medication robot. Pharmacies, which currently order dose packaging machines from Ti Medi, will now be able to offer consumers a complete solution where Dosell is delivered together with the dose bags produced by Ti Medi's machines. This integrated system will enable the consolidation of all data, allowing pharmacists to monitor patients' medication adherence in a new and efficient manner.

"We are delighted to collaborate with iZafe Group and to include Dosell in our new concept for the Spanish market. With this new customer journey, we can now combine our dose packaging machines with the Dosell medication dispenser, thereby offering our pharmacies a unique and comprehensive innovative solution that will improve patients' adherence to their medication," says Marc Tarruell Tibau, CEO of Ti Medi.

"After a year of dedicated work with Ti Medi, we are now seeing tangible results from our efforts to create a targeted customer journey for the Spanish market. This order demonstrates the high efficiency of our joint venture, and we are pleased that the Spanish market can now begin using Dosell. Our technology and capacity, combined with the simplicity of our solution, will make a real difference for both pharmacists and patients," says Anders Segerström, CEO of iZafe Group.

iZafe Group (publ.) hereby announces that CEO Anders Segerström will present on Tuesday, June 11 at 11:45 AM at Stora Aktiedagarna in Stockholm.

On Tuesday, June 11 at 11:45 AM, iZafe will present its business at Stora Aktiedagarna in Stockholm. The address is Birger Jarlsgatan 61 A. The presentation will also be broadcast live and available afterwards on Aktiespararna's YouTube channel as well as on iZafe's website.
 
More information can be found via this link: https://www.aktiespararna.se/aktiviteter/aktiedagarna-i-stockholm-42149

iZafe Group AB ("iZafe Group") announces that their partner Zafe Care Systems AB ("Zafe") has been awarded a contract in a procurement process with Kristianstad Municipality for the provision of iZafe's medication dispensers Dosell. The procurement includes 150-190 units, with an estimated value of 3.7-4.3 MSEK. The contract is between Zafe and iZafe Group's wholly owned subsidiary Dosell AB.

The contract period extends over four years, from 2024 to 2028. The order value of 3.7-4.3 MSEK reflects the total value for Dosell and iZafe Group.

"It is an honor to collaborate with a leading player in automated medication dispensing. With Dosell, we can ensure that patients receive the right medication at the right time, reducing the risk of medication errors and increasing security for both patients and their relatives. Together with Sensorem, we can further enhance patient independence by reminding them to take their medication on time. Our technology creates independence and security, and we are proud to contribute to safer healthcare.

Zafe stands for down-to-earth and caring service, always with flexible solutions tailored to individual needs." says Per La Fleur, CEO of Zafe Care Systems.

iZafe Group AB ("iZafe Group"), in collaboration with Atea Sverige AB, is proud to announce their presence at Vitalis 2024, the Nordic region's leading venue for the future of health, care, and welfare. As part of Atea Sverige's extensive exhibition, iZafe Group will be showcased in Atea's booth. The fair will take place at the Swedish Exhibition & Congress Centre in Gothenburg from May 14 to May 16.

Vitalis is an arena where e-health, welfare technology, and innovation are in focus. It brings together leading industry players to exchange knowledge about challenges and solutions and to discuss how visions can be transformed into reality. As a prominent player in the healthcare technology field, iZafe Group will showcase its latest advancements and solutions, including the innovative medication robot, Dosell. Their presence at the fair also marks an important milestone following the procurement win to supply Dosell to the Västra Götaland Region (VGR). This underscores iZafe Group's commitment to enhancing the independence and safety of care recipients through advanced technology.

During Vitalis, the iZafe team looks forward to demonstrating how Dosell can play a crucial role in improving the quality of life for care recipients, facilitating healthcare personnel within municipalities, and streamlining medication management. This is part of the company's broader goal to deliver solutions that meet the high demands of today's healthcare and care landscape.

iZafe Group welcomes all visitors to booth B10:10, where the company’s team of experts will be available to discuss how iZafe’s products and services can help improve efficiency and quality in the healthcare sector. For more information about our presence at Vitalis and to register for the event, visit here.

iZafe Group AB ("iZafe Group") today announces that Ida Almgren has decided to step down as Chief Financial Officer to explore new career opportunities.

During the transition period, Ida will actively assist iZafe Group to ensure a smooth transition, while a search process for a new CFO commences. Ida's last day of work will be June 18.

iZafe is deeply committed to a stable transition and to continuously delivering value to our shareholders and stakeholders. We are fully focused on executing our long-term strategy and realizing our business plans with precision and determination.

iZafe Group AB ("iZafe Group") is pleased to announce the launch of Dosell version 3.0, the latest edition of our revolutionary medication robot, designed to optimize medication management for users worldwide. In connection with this launch, iZafe Group has also initiated a strategic move of its production to Central Europe in order to be able to scale up the production rate to larger volumes and shorten the delivery distances to existing partners.

The first production run of 1,000 pieces of Dosell version 3.0 has been successfully completed and delivered for the Dutch market, marking the starting point for this new and improved version. With, among other things, a more powerful processor and increased memory capacity, Dosell version 3.0 now enables a unified software platform regardless of geographical location or design of the sachet bag. This represents a significant improvement from previous versions that required extensive customization for each individual country and sachet type. In addition, the new version of Dosell 3.0 introduces several advanced features, including voice and expanded connectivity options, further improving the user experience and accessibility.

"The launch of Dosell version 3.0 is an important milestone for us. The new components in this version not only enable a higher and better performance of existing functions, but also open up a wide range of new and innovative functions in the future. All this, without significantly affect the production cost, thanks to the progress made in the component market since Dosell's first version was developed." Says Anders Segerström, CEO of Zafe Group.

This strategic investment in innovation and product development, together with the relocation of production to Central Europe, positions iZafe Group at the forefront of medical technology solutions. With Dosell version 3.0, iZafe Group can now offer an even more reliable and efficient medicine management solution, making it easier for users worldwide to take the right medicine at the right time.

Webbdesign av Comlog Webbyrå Stockholm